Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir V Kaisary

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BJU International|March 30, 2005
The incidence and treatment of lymphoceles after radical retropubic prostatectomyRuth J Pepper, Jhumur Pati, Amir V Kaisary
BJU International|July 13, 2006
Nanotechnology: potential applications in urologyAthanasios Tsiouris, Hashim U Ahmed, Amir V Kaisary
Journal of Clinical Medicine Research|June 2, 2011
Wilms tumor in a 37-year-oldGowreeson Thevendran, Hugo A Farne, Amir V Kaisary
Annals of the Royal College of Surgeons of England|June 6, 2006
Incarcerated small bowel hernia through drain siteShailesh Kulkarni, Brandon Krijgsman, Dinesh Sharma, et al.
Annals of the Royal College of Surgeons of England|January 19, 2008
Urachal tumour: clinical and radiological features of a poorly understood carcinomaAthanasios Tsiouris, Hashim Uddin Ahmed, Nittin Kumar, et al.
British Journal of Hospital Medicine (London, England : 2005)|December 1, 2006
The ligated ureter: beware or be awareAthanasios Tsiouris, Hashim U Ahmed, Nick Woodward, et al.
Hormone Research|October 23, 2004
Pharmacodynamic equivalence of a decapeptyl 3-month SR formulation with the 28-day SR formulation in patients with advanced prostate cancerPierre Teillac, Christiaan F Heyns, Amir V Kaisary, et al.
BJU International|July 13, 2006
Radiommunotherapy and prostate cancer: a promising new therapy in the management of metastatic diseaseAzhar Khan, Iqbal Shergill, Manit Arya, et al.
Tissue & Cell|March 26, 2004
In vitro deregulation of markers characteristic of human prostate epithelial cellsTarin A Islam, Anup Patel, Amir V Kaisary, et al.
BJU International|June 15, 2006
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castrationChris J Tyrrell, Peter Iversen, Teuvo Tammela, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BJU International|March 30, 2005
The incidence and treatment of lymphoceles after radical retropubic prostatectomyRuth J Pepper, Jhumur Pati, Amir V Kaisary
BJU International|July 13, 2006
Nanotechnology: potential applications in urologyAthanasios Tsiouris, Hashim U Ahmed, Amir V Kaisary
Journal of Clinical Medicine Research|June 2, 2011
Wilms tumor in a 37-year-oldGowreeson Thevendran, Hugo A Farne, Amir V Kaisary
Annals of the Royal College of Surgeons of England|June 6, 2006
Incarcerated small bowel hernia through drain siteShailesh Kulkarni, Brandon Krijgsman, Dinesh Sharma, et al.
Annals of the Royal College of Surgeons of England|January 19, 2008
Urachal tumour: clinical and radiological features of a poorly understood carcinomaAthanasios Tsiouris, Hashim Uddin Ahmed, Nittin Kumar, et al.
British Journal of Hospital Medicine (London, England : 2005)|December 1, 2006
The ligated ureter: beware or be awareAthanasios Tsiouris, Hashim U Ahmed, Nick Woodward, et al.
Hormone Research|October 23, 2004
Pharmacodynamic equivalence of a decapeptyl 3-month SR formulation with the 28-day SR formulation in patients with advanced prostate cancerPierre Teillac, Christiaan F Heyns, Amir V Kaisary, et al.
BJU International|July 13, 2006
Radiommunotherapy and prostate cancer: a promising new therapy in the management of metastatic diseaseAzhar Khan, Iqbal Shergill, Manit Arya, et al.
Tissue & Cell|March 26, 2004
In vitro deregulation of markers characteristic of human prostate epithelial cellsTarin A Islam, Anup Patel, Amir V Kaisary, et al.
BJU International|June 15, 2006
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castrationChris J Tyrrell, Peter Iversen, Teuvo Tammela, et al.
Pageof 2